0001410578-25-002156.txt : 20250912 0001410578-25-002156.hdr.sgml : 20250912 20250911184345 ACCESSION NUMBER: 0001410578-25-002156 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250912 DATE AS OF CHANGE: 20250911 EFFECTIVENESS DATE: 20250912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Psy Therapeutics, Inc. CENTRAL INDEX KEY: 0001788222 ORGANIZATION NAME: EIN: 464703014 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-426963 FILM NUMBER: 251309636 BUSINESS ADDRESS: STREET 1: 28 ATLANTIC AVE, SUITE 129 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (617) 723-5429 MAIL ADDRESS: STREET 1: 28 ATLANTIC AVE, SUITE 129 CITY: BOSTON STATE: MA ZIP: 02110 D/A 1 primary_doc.xml X0708 D/A LIVE 0001788222 Psy Therapeutics, Inc. 28 ATLANTIC AVE, SUITE 222 BOSTON MA MASSACHUSETTS 02110 (617) 723-5429 DELAWARE PsyBrain, Inc. None Corporation true David S. Barlow c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Executive Officer Director Jeff Troderman c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Executive Officer Alan Cross c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Director Daniel Weiss Pick c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Director Jerry F. Rosenbaum c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Director William Wagner c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Executive Officer Paul Murphy c/o Psy Therapeutics, Inc. 28 Atlantic Ave, Suite 222 Boston MA MASSACHUSETTS 02110 Director Pharmaceuticals Decline to Disclose 06b true 0001104659-24-087782 2021-12-23 true true true true false 0 20400000 6762848 13637152 Amount sold includes $1,772,615 of principal and accrued interest on certain prior convertible promissory notes which were converted to First Tranche Convertible Promissory Notes. false 23 0 0 0 false Psy Therapeutics, Inc. /s/ David S. Barlow David S. Barlow Chief Executive Officer 2025-09-09